What is the Small Molecule Drug Discovery Market?

The Small Molecule Drug Discovery Market focuses on the development and discovery of small molecule drugs, which are low molecular weight compounds used to treat various diseases, including cancer and cardiovascular disorders.

How big is the Small Molecule Drug Discovery Market?

The global Small Molecule Drug Discovery Market size was estimated at USD 52.5 Billion in 2023 and is expected to reach USD 121.8 Billion in 2033.

What is the Small Molecule Drug Discovery Market growth?

The global Small Molecule Drug Discovery Market is expected to grow at a compound annual growth rate of 8.8%. From 2024 To 2033

Who are the key companies/players in the Small Molecule Drug Discovery Market?

Some of the key players in the Small Molecule Drug Discovery Markets are Pfizer Inc., GlaxoSmithKline PLC, Merck & Co. Inc., Agilent Technologies Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Bayer AG, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Shimadzu Corp, Halia Therapeutics, and Sibylla Biotech.

Which regions are leading in the Small Molecule Drug Discovery market?

North America dominated the market with the highest revenue share of 36.8%

What are the key drivers of this market?

Key drivers include the rising prevalence of chronic diseases, advancements in drug discovery technologies, and increased R&D investments by pharmaceutical companies.

What are small molecule drugs?

Small molecule drugs are chemically synthesized compounds that can easily enter cells and modulate biological processes, making them effective in treating a wide range of diseases.

What challenges does the market face?

Challenges include high development costs, lengthy approval processes, and competition from biologics and large molecule drugs.

What role does AI play in this market?

AI and machine learning are revolutionizing the drug discovery process, making it faster, more accurate, and cost-efficient, particularly in identifying potential small molecule drug candidates.

Global Small Molecule Drug Discovery Market By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, and Other Therapeutic Areas), By Process/Phase (Target ID/Validation, Hit Generation and Selection, Lead Identification, and Lead Optimization), By End-user (Pharmaceutical companies, Biotechnology companies, Contract research organizations (CROs), and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Aug 2024
Report ID: 127107
Number of Pages: 246
Format:

Table of Contents
- 1. Executive Summary
- 1.1. Definition
- 1.2. Market Snapshot
- 1.3. Market Overview
- 1.4. Segment Overview
- 1.5. Regional Overview
- 1.6. Competitive Landscape
- 1.7. Taxonomy
- 2. Global Market Overview
- 2.1. Global Market Insights and Industry Overview
- 2.2. Market Dynamics
  - 2.2.1. Drivers
  - 2.2.2. Restraints
  - 2.2.3. Opportunities
  - 2.2.4. Key Small Molecule Drug Discovery Market Trends
- 2.3. Regulatory Framework
- 2.4. Opportunity Map Analysis
- 2.5. Opportunity Orbits
- 2.6. PESTLE Analysis
- 2.7. PORTER’S Five Force Analysis
- 2.8. Drivers & Restraints Impact Analysis
- 2.9. Value Chain Analysis
  - 2.9.1. List of Raw Materials Suppliers
  - 2.9.2. List of Small Molecule Drug Discovery Manufacturers
  - 2.9.3. List of Dealer/Distributors
- 2.10. Regional Market Share and BPS Analysis
- 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Small Molecule Drug Discovery Market Analysis and Forecast, By Segment, 2019-2033
- 3.1. Key Findings
- 3.2. Global Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2019-2033
- 3.3. Global Small Molecule Drug Discovery Market Attractiveness Analysis, By Therapeutic Area
  - 3.3.1. Oncology
    
    3.3.1.1. Insights
    
    3.3.1.2. Key Takeaways
  - 3.3.2. Central Nervous System
    
    3.3.2.1. Insights
    
    3.3.2.2. Key Takeaways
  - 3.3.3. Cardiovascular
    
    3.3.3.1. Insights
    
    3.3.3.2. Key Takeaways
  - 3.3.4. Respiratory
    
    3.3.4.1. Insights
    
    3.3.4.2. Key Takeaways
  - 3.3.5. Metabolic Disorders
    
    3.3.5.1. Insights
    
    3.3.5.2. Key Takeaways
  - 3.3.6. Gastrointestinal
    
    3.3.6.1. Insights
    
    3.3.6.2. Key Takeaways
  - 3.3.7. Other Therapeutic Areas
    
    3.3.7.1. Insights
    
    3.3.7.2. Key Takeaways
- 3.4. Global Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process/Phase, 2019-2033
- 3.5. Global Small Molecule Drug Discovery Market Attractiveness Analysis, By Process/Phase
  - 3.5.1. Target ID/Validation
    
    3.5.1.1. Insights
    
    3.5.1.2. Key Takeaways
  - 3.5.2. Hit Generation and Selection
    
    3.5.2.1. Insights
    
    3.5.2.2. Key Takeaways
  - 3.5.3. Lead Identification
    
    3.5.3.1. Insights
    
    3.5.3.2. Key Takeaways
  - 3.5.4. Lead Optimization
    
    3.5.4.1. Insights
    
    3.5.4.2. Key Takeaways
- 3.6. Global Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End Users, 2019-2033
- 3.7. Global Small Molecule Drug Discovery Market Attractiveness Analysis, By End Users
  - 3.7.1. Pharmaceutical companies
    
    3.7.1.1. Insights
    
    3.7.1.2. Key Takeaways
  - 3.7.2. Biotechnology companies
    
    3.7.2.1. Insights
    
    3.7.2.2. Key Takeaways
  - 3.7.3. Contract research organizations (CROs)
    
    3.7.3.1. Insights
    
    3.7.3.2. Key Takeaways
  - 3.7.4. Others
    
    3.7.4.1. Insights
    
    3.7.4.2. Key Takeaways
- 4. Global Small Molecule Drug Discovery Market Analysis and Forecast, By Region, 2019-2033
- 4.1. Key Findings
- 4.2. Global Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
  - 4.2.1. North America
    
    4.2.1.1. Regional Insights
  - 4.2.2. Europe
    
    4.2.2.1. Regional Insights
  - 4.2.3. Asia Pacific
    
    4.2.3.1. Regional Insights
  - 4.2.4. Latin America
    
    4.2.4.1. Regional Insights
  - 4.2.5. Middle East & Africa
    
    4.2.5.1. Regional Insights
- 4.3. Global Small Molecule Drug Discovery Market Attractiveness Analysis, By Region
- 5. North America Small Molecule Drug Discovery Market Analysis and Forecast, 2019-2033
- 5.1. Key Findings
- 5.2. North America Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2019-2033
- 5.3. North America Small Molecule Drug Discovery Market Attractiveness Analysis, By Therapeutic Area
- 5.4. North America Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process/Phase, 2019-2033
- 5.5. North America Small Molecule Drug Discovery Market Attractiveness Analysis, By Process/Phase
- 5.6. North America Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End Users, 2019-2033
- 5.7. North America Small Molecule Drug Discovery Market Attractiveness Analysis, By End Users
- 5.8. North America Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 5.9. North America Small Molecule Drug Discovery Market Attractiveness Analysis, By Country
  - 5.9.1. The US
  - 5.9.2. Canada
- 6. Europe Small Molecule Drug Discovery Market Analysis and Forecast, 2019-2033
- 6.1. Key Findings
- 6.2. Europe Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2019-2033
- 6.3. Europe Small Molecule Drug Discovery Market Attractiveness Analysis, By Therapeutic Area
- 6.4. Europe Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process/Phase, 2019-2033
- 6.5. Europe Small Molecule Drug Discovery Market Attractiveness Analysis, By Process/Phase
- 6.6. Europe Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End Users, 2019-2033
- 6.7. Europe Small Molecule Drug Discovery Market Attractiveness Analysis, By End Users
- 6.8. Europe Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 6.9. Europe Small Molecule Drug Discovery Market Attractiveness Analysis, By Country
  - 6.9.1. Germany
  - 6.9.2. The UK
  - 6.9.3. France
  - 6.9.4. Spain
  - 6.9.5. Italy
  - 6.9.6. Russia
  - 6.9.7. Netherland
  - 6.9.8. Rest of Europe
- 7. Asia Pacific Small Molecule Drug Discovery Market Analysis and Forecast, 2019-2033
- 7.1. Key Findings
- 7.2. Asia Pacific Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2019-2033
- 7.3. Asia Pacific Small Molecule Drug Discovery Market Attractiveness Analysis, By Therapeutic Area
- 7.4. Asia Pacific Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process/Phase, 2019-2033
- 7.5. Asia Pacific Small Molecule Drug Discovery Market Attractiveness Analysis, By Process/Phase
- 7.6. Asia Pacific Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End Users, 2019-2033
- 7.7. Asia Pacific Small Molecule Drug Discovery Market Attractiveness Analysis, By End Users
- 7.8. Asia Pacific Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 7.9. Asia Pacific Small Molecule Drug Discovery Market Attractiveness Analysis, By Country
  - 7.9.1. China
  - 7.9.2. Japan
  - 7.9.3. South Korea
  - 7.9.4. India
  - 7.9.5. Australia
  - 7.9.6. New Zealand
  - 7.9.7. Singapore
  - 7.9.8. Thailand
  - 7.9.9. Vietnam
  - 7.9.10. Rest of Asia Pacific
- 8. Latin America Small Molecule Drug Discovery Market Analysis and Forecast, 2019-2033
- 8.1. Key Findings
- 8.2. Latin America Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2019-2033
- 8.3. Latin America Small Molecule Drug Discovery Market Attractiveness Analysis, By Therapeutic Area
- 8.4. Latin America Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process/Phase, 2019-2033
- 8.5. Latin America Small Molecule Drug Discovery Market Attractiveness Analysis, By Process/Phase
- 8.6. Latin America Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End Users, 2019-2033
- 8.7. Latin America Small Molecule Drug Discovery Market Attractiveness Analysis, By End Users
- 8.8. Latin America Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 8.9. Latin America Small Molecule Drug Discovery Market Attractiveness Analysis, By Country
  - 8.9.1. Brazil
  - 8.9.2. Mexico
  - 8.9.3. Rest of Latin America
- 9. Middle East & Africa Small Molecule Drug Discovery Market Analysis and Forecast, 2019-2033
- 9.1. Key Findings
- 9.2. Middle East & Africa Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2019-2033
- 9.3. Middle East & Africa Small Molecule Drug Discovery Market Attractiveness Analysis, By Therapeutic Area
- 9.4. Middle East & Africa Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process/Phase, 2019-2033
- 9.5. Middle East & Africa Small Molecule Drug Discovery Market Attractiveness Analysis, By Process/Phase
- 9.6. Middle East & Africa Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End Users, 2019-2033
- 9.7. Middle East & Africa Small Molecule Drug Discovery Market Attractiveness Analysis, By End Users
- 9.8. Middle East & Africa Small Molecule Drug Discovery Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 9.9. Middle East & Africa Small Molecule Drug Discovery Market Attractiveness Analysis, By Country
  - 9.9.1. South Africa
  - 9.9.2. Saudi Arabia
  - 9.9.3. UAE
  - 9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
- 10.1. Market Competition Scenario Analysis, By Company
  - 10.1.1. Key Takeaways
- 10.2. Overview of Major Market Players
- 10.3. Competitor Landscape
- 10.4. Strategic Mapping
- 10.5. Company Life Cycle Analysis
- 10.6. Company Market Share Analysis
- 10.7. Company Profiles
  - 10.7.1. Pfizer Inc.
    
    10.7.1.1. Company Details
    
    10.7.1.2. Business Overview
    
    10.7.1.3. Product Portfolio
    
    10.7.1.4. Financial Insights
    
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.1.6. SWOT Analysis
    
    10.7.1.7. Geographic Footprint
  - 10.7.2. GlaxoSmithKline PLC
    
    10.7.2.1. Company Details
    
    10.7.2.2. Business Overview
    
    10.7.2.3. Product Portfolio
    
    10.7.2.4. Financial Insights
    
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.2.6. SWOT Analysis
    
    10.7.2.7. Geographic Footprint
  - 10.7.3. Merck & Co. Inc.
    
    10.7.3.1. Company Details
    
    10.7.3.2. Business Overview
    
    10.7.3.3. Product Portfolio
    
    10.7.3.4. Financial Insights
    
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.3.6. SWOT Analysis
    
    10.7.3.7. Geographic Footprint
  - 10.7.4. Agilent Technologies Inc.
    
    10.7.4.1. Company Details
    
    10.7.4.2. Business Overview
    
    10.7.4.3. Product Portfolio
    
    10.7.4.4. Financial Insights
    
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.4.6. SWOT Analysis
    
    10.7.4.7. Geographic Footprint
  - 10.7.5. Eli Lilly and Company
    
    10.7.5.1. Company Details
    
    10.7.5.2. Business Overview
    
    10.7.5.3. Product Portfolio
    
    10.7.5.4. Financial Insights
    
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.5.6. SWOT Analysis
    
    10.7.5.7. Geographic Footprint
  - 10.7.6. F. Hoffmann-La Roche Ltd
    
    10.7.6.1. Company Details
    
    10.7.6.2. Business Overview
    
    10.7.6.3. Product Portfolio
    
    10.7.6.4. Financial Insights
    
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.6.6. SWOT Analysis
    
    10.7.6.7. Geographic Footprint
  - 10.7.7. Bayer AG
    
    10.7.7.1. Company Details
    
    10.7.7.2. Business Overview
    
    10.7.7.3. Product Portfolio
    
    10.7.7.4. Financial Insights
    
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.7.6. SWOT Analysis
    
    10.7.7.7. Geographic Footprint
  - 10.7.8. Abbott Laboratories Inc.
    
    10.7.8.1. Company Details
    
    10.7.8.2. Business Overview
    
    10.7.8.3. Product Portfolio
    
    10.7.8.4. Financial Insights
    
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.8.6. SWOT Analysis
    
    10.7.8.7. Geographic Footprint
  - 10.7.9. Thermo Fisher Scientific Inc.
    
    10.7.9.1. Company Details
    
    10.7.9.2. Business Overview
    
    10.7.9.3. Product Portfolio
    
    10.7.9.4. Financial Insights
    
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.9.6. SWOT Analysis
    
    10.7.9.7. Geographic Footprint
  - 10.7.10. Shimadzu Corp
    
    10.7.10.1. Company Details
    
    10.7.10.2. Business Overview
    
    10.7.10.3. Product Portfolio
    
    10.7.10.4. Financial Insights
    
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.10.6. SWOT Analysis
    
    10.7.10.7. Geographic Footprint
  - 10.7.11. Other Key Players
    
    10.7.11.1. Company Details
    
    10.7.11.2. Business Overview
    
    10.7.11.3. Product Portfolio
    
    10.7.11.4. Financial Insights
    
    10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.11.6. SWOT Analysis
    
    10.7.11.7. Geographic Footprint
- 11. Methodology and Data Source
- 11.1. Methodology/Research Approach
- 11.2. Market Size Estimation
- 11.3. Market Breakdown and Data Triangulation
- 11.4. Data Source
- 11.5. Secondary Sources
- 11.6. Primary Sources
- 11.7. Appendix
- 11.8. Disclaimer
List of Tables
- Table 1. Global Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 2. Global Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 3. Global Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 4. Global Small Molecule Drug Discovery Market Value (US$ Mn), By Region, 2019-2033
- Table 5. North America Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 6. North America Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 7. North America Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 8. North America Small Molecule Drug Discovery Market Value (US$ Mn), By Country, 2019-2033
- Table 9. The US Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 10. The US Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 11. The US Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 12. Canada Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 13. Canada Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 14. Canada Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 15. Europe Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 16. Europe Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 17. Europe Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 18. Europe Small Molecule Drug Discovery Market Value (US$ Mn), By Country, 2019-2033
- Table 19. Germany Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 20. Germany Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 21. Germany Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 22. The UK Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 23. The UK Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 24. The UK Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 25. France Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 26. France Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 27. France Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 28. Spain Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 29. Spain Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 30. Spain Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 31. Italy Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 32. Italy Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 33. Italy Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 34. Russia Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 35. Russia Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 36. Russia Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 37. Netherland Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 38. Netherland Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 39. Netherland Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 40. Rest of Europe Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 41. Rest of Europe Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 42. Rest of Europe Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 43. Asia Pacific Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 44. Asia Pacific Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 45. Asia Pacific Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 46. Asia Pacific Small Molecule Drug Discovery Market Value (US$ Mn), By Country, 2019-2033
- Table 47. China Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 48. China Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 49. China Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 50. India Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 51. India Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 52. India Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 53. Japan Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 54. Japan Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 55. Japan Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 56. South Korea Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 57. South Korea Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 58. South Korea Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 59. Australia Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 60. Australia Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 61. Australia Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 62. New Zealand Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 63. New Zealand Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 64. New Zealand Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 65. Singapore Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 66. Singapore Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 67. Singapore Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 68. Thailand Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 69. Thailand Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 70. Thailand Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 71. Vietnam Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 72. Vietnam Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 73. Vietnam Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 74. Rest of Asia Pacific Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 75. Rest of Asia Pacific Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 76. Rest of Asia Pacific Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 77. Latin America Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 78. Latin America Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 79. Latin America Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 80. Latin America Small Molecule Drug Discovery Market Value (US$ Mn), By Country, 2019-2033
- Table 81. Brazil Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 82. Brazil Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 83. Brazil Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 84. Mexico Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 85. Mexico Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 86. Mexico Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 87. Rest of Latin America Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 88. Rest of Latin America Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 89. Rest of Latin America Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 90. Middle East & Africa Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 91. Middle East & Africa Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 92. Middle East & Africa Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 93. Middle East & Africa Small Molecule Drug Discovery Market Value (US$ Mn), By Country, 2019-2033
- Table 94. South Africa Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 95. South Africa Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 96. South Africa Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 97. Saudi Arabia Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 98. Saudi Arabia Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 99. Saudi Arabia Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 100. UAE Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 101. UAE Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 102. UAE Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
- Table 103. Rest of Middle East & Africa Small Molecule Drug Discovery Market Value (US$ Mn), By Therapeutic Area, 2019-2033
- Table 104. Rest of Middle East & Africa Small Molecule Drug Discovery Market Value (US$ Mn), By Process/Phase, 2019-2033
- Table 105. Rest of Middle East & Africa Small Molecule Drug Discovery Market Value (US$ Mn), By End Users, 2019-2033
List of Figures
- Figure 1. Global Small Molecule Drug Discovery Market Snapshot: Market Value (US$ Mn), 2019-2033
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in Small Molecule Drug Discovery Market
- Figure 5. Global Small Molecule Drug Discovery Market Analysis, By Therapeutic Area, 2019, 2023 and 2033
- Figure 6. Global Small Molecule Drug Discovery Market Attractiveness Analysis, By Therapeutic Area
- Figure 7. Global Small Molecule Drug Discovery Market Analysis, By Process/Phase, 2019, 2023 and 2033
- Figure 8. Global Small Molecule Drug Discovery Market Attractiveness Analysis, By Process/Phase
- Figure 9. Global Small Molecule Drug Discovery Market Analysis, By End Users, 2019, 2023 and 2033
- Figure 10. Global Small Molecule Drug Discovery Market Attractiveness Analysis, By End Users
- Figure 11. Global Small Molecule Drug Discovery Market Analysis, By Region, 2019, 2023 and 2033
- Figure 12. Global Small Molecule Drug Discovery Market Attractiveness Analysis, By Region
- Figure 13. North America Small Molecule Drug Discovery Market Analysis, By Therapeutic Area, 2019, 2023 and 2033
- Figure 14. North America Small Molecule Drug Discovery Market Attractiveness Analysis, By Therapeutic Area
- Figure 15. North America Small Molecule Drug Discovery Market (US$ Mn), by Oncology, 2019-2033
- Figure 16. North America Small Molecule Drug Discovery Market (US$ Mn), by Central Nervous System, 2019-2033
- Figure 17. North America Small Molecule Drug Discovery Market (US$ Mn), by Cardiovascular, 2019-2033
- Figure 18. North America Small Molecule Drug Discovery Market (US$ Mn), by Respiratory, 2019-2033
- Figure 19. North America Small Molecule Drug Discovery Market (US$ Mn), by Metabolic Disorders, 2019-2033
- Figure 20. North America Small Molecule Drug Discovery Market (US$ Mn), by Gastrointestinal, 2019-2033
- Figure 21. North America Small Molecule Drug Discovery Market (US$ Mn), by Other Therapeutic Areas, 2019-2033
- Figure 22. North America Small Molecule Drug Discovery Market Analysis, By Process/Phase, 2019, 2023 and 2033
- Figure 23. North America Small Molecule Drug Discovery Market Attractiveness Analysis, By Process/Phase
- Figure 24. North America Small Molecule Drug Discovery Market (US$ Mn), by Target ID/Validation, 2019-2033
- Figure 25. North America Small Molecule Drug Discovery Market (US$ Mn), by Hit Generation and Selection, 2019-2033
- Figure 26. North America Small Molecule Drug Discovery Market (US$ Mn), by Lead Identification, 2019-2033
- Figure 27. North America Small Molecule Drug Discovery Market (US$ Mn), by Lead Optimization, 2019-2033
- Figure 28. North America Small Molecule Drug Discovery Market Analysis, By End Users, 2019, 2023 and 2033
- Figure 29. North America Small Molecule Drug Discovery Market Attractiveness Analysis, By End Users
- Figure 30. North America Small Molecule Drug Discovery Market (US$ Mn), by Pharmaceutical companies, 2019-2033
- Figure 31. North America Small Molecule Drug Discovery Market (US$ Mn), by Biotechnology companies, 2019-2033
- Figure 32. North America Small Molecule Drug Discovery Market (US$ Mn), by Contract research organizations (CROs), 2019-2033
- Figure 33. North America Small Molecule Drug Discovery Market (US$ Mn), by Others, 2019-2033
- Figure 34. North America Small Molecule Drug Discovery Market Analysis, By Country, 2019, 2023 and 2033
- Figure 35. North America Small Molecule Drug Discovery Market Attractiveness Analysis, By Country
- Figure 36. Europe Small Molecule Drug Discovery Market Analysis, By Therapeutic Area, 2019, 2023 and 2033
- Figure 37. Europe Small Molecule Drug Discovery Market Attractiveness Analysis, By Therapeutic Area
- Figure 38. Europe Small Molecule Drug Discovery Market (US$ Mn), by Oncology, 2019-2033
- Figure 39. Europe Small Molecule Drug Discovery Market (US$ Mn), by Central Nervous System, 2019-2033
- Figure 40. Europe Small Molecule Drug Discovery Market (US$ Mn), by Cardiovascular, 2019-2033
- Figure 41. Europe Small Molecule Drug Discovery Market (US$ Mn), by Respiratory, 2019-2033
- Figure 42. Europe Small Molecule Drug Discovery Market (US$ Mn), by Metabolic Disorders, 2019-2033
- Figure 43. Europe Small Molecule Drug Discovery Market (US$ Mn), by Gastrointestinal, 2019-2033
- Figure 44. Europe Small Molecule Drug Discovery Market (US$ Mn), by Other Therapeutic Areas, 2019-2033
- Figure 45. Europe Small Molecule Drug Discovery Market Analysis, By Process/Phase, 2019, 2023 and 2033
- Figure 46. Europe Small Molecule Drug Discovery Market Attractiveness Analysis, By Process/Phase
- Figure 47. Europe Small Molecule Drug Discovery Market (US$ Mn), by Target ID/Validation, 2019-2033
- Figure 48. Europe Small Molecule Drug Discovery Market (US$ Mn), by Hit Generation and Selection, 2019-2033
- Figure 49. Europe Small Molecule Drug Discovery Market (US$ Mn), by Lead Identification, 2019-2033
- Figure 50. Europe Small Molecule Drug Discovery Market (US$ Mn), by Lead Optimization, 2019-2033
- Figure 51. Europe Small Molecule Drug Discovery Market Analysis, By End Users, 2019, 2023 and 2033
- Figure 52. Europe Small Molecule Drug Discovery Market Attractiveness Analysis, By End Users
- Figure 53. Europe Small Molecule Drug Discovery Market (US$ Mn), by Pharmaceutical companies, 2019-2033
- Figure 54. Europe Small Molecule Drug Discovery Market (US$ Mn), by Biotechnology companies, 2019-2033
- Figure 55. Europe Small Molecule Drug Discovery Market (US$ Mn), by Contract research organizations (CROs), 2019-2033
- Figure 56. Europe Small Molecule Drug Discovery Market (US$ Mn), by Others, 2019-2033
- Figure 57. Europe Small Molecule Drug Discovery Market Analysis, By Country, 2019, 2023 and 2033
- Figure 58. Europe Small Molecule Drug Discovery Market Attractiveness Analysis, By Country
- Figure 59. Asia Pacific Small Molecule Drug Discovery Market Analysis, By Therapeutic Area, 2019, 2023 and 2033
- Figure 60. Asia Pacific Small Molecule Drug Discovery Market Attractiveness Analysis, By Therapeutic Area
- Figure 61. Asia Pacific Small Molecule Drug Discovery Market (US$ Mn), by Oncology, 2019-2033
- Figure 62. Asia Pacific Small Molecule Drug Discovery Market (US$ Mn), by Central Nervous System, 2019-2033
- Figure 63. Asia Pacific Small Molecule Drug Discovery Market (US$ Mn), by Cardiovascular, 2019-2033
- Figure 64. Asia Pacific Small Molecule Drug Discovery Market (US$ Mn), by Respiratory, 2019-2033
- Figure 65. Asia Pacific Small Molecule Drug Discovery Market (US$ Mn), by Metabolic Disorders, 2019-2033
- Figure 66. Asia Pacific Small Molecule Drug Discovery Market (US$ Mn), by Gastrointestinal, 2019-2033
- Figure 67. Asia Pacific Small Molecule Drug Discovery Market (US$ Mn), by Other Therapeutic Areas, 2019-2033
- Figure 68. Asia Pacific Small Molecule Drug Discovery Market Analysis, By Process/Phase, 2019, 2023 and 2033
- Figure 69. Asia Pacific Small Molecule Drug Discovery Market Attractiveness Analysis, By Process/Phase
- Figure 70. Asia Pacific Small Molecule Drug Discovery Market (US$ Mn), by Target ID/Validation, 2019-2033
- Figure 71. Asia Pacific Small Molecule Drug Discovery Market (US$ Mn), by Hit Generation and Selection, 2019-2033
- Figure 72. Asia Pacific Small Molecule Drug Discovery Market (US$ Mn), by Lead Identification, 2019-2033
- Figure 73. Asia Pacific Small Molecule Drug Discovery Market (US$ Mn), by Lead Optimization, 2019-2033
- Figure 74. Asia Pacific Small Molecule Drug Discovery Market Analysis, By End Users, 2019, 2023 and 2033
- Figure 75. Asia Pacific Small Molecule Drug Discovery Market Attractiveness Analysis, By End Users
- Figure 76. Asia Pacific Small Molecule Drug Discovery Market (US$ Mn), by Pharmaceutical companies, 2019-2033
- Figure 77. Asia Pacific Small Molecule Drug Discovery Market (US$ Mn), by Biotechnology companies, 2019-2033
- Figure 78. Asia Pacific Small Molecule Drug Discovery Market (US$ Mn), by Contract research organizations (CROs), 2019-2033
- Figure 79. Asia Pacific Small Molecule Drug Discovery Market (US$ Mn), by Others, 2019-2033
- Figure 80. Asia Pacific Small Molecule Drug Discovery Market Analysis, By Country, 2019, 2023 and 2033
- Figure 81. Asia Pacific Small Molecule Drug Discovery Market Attractiveness Analysis, By Country
- Figure 82. Latin America Small Molecule Drug Discovery Market Analysis, By Therapeutic Area, 2019, 2023 and 2033
- Figure 83. Latin America Small Molecule Drug Discovery Market Attractiveness Analysis, By Therapeutic Area
- Figure 84. Latin America Small Molecule Drug Discovery Market (US$ Mn), by Oncology, 2019-2033
- Figure 85. Latin America Small Molecule Drug Discovery Market (US$ Mn), by Central Nervous System, 2019-2033
- Figure 86. Latin America Small Molecule Drug Discovery Market (US$ Mn), by Cardiovascular, 2019-2033
- Figure 87. Latin America Small Molecule Drug Discovery Market (US$ Mn), by Respiratory, 2019-2033
- Figure 88. Latin America Small Molecule Drug Discovery Market (US$ Mn), by Metabolic Disorders, 2019-2033
- Figure 89. Latin America Small Molecule Drug Discovery Market (US$ Mn), by Gastrointestinal, 2019-2033
- Figure 90. Latin America Small Molecule Drug Discovery Market (US$ Mn), by Other Therapeutic Areas, 2019-2033
- Figure 91. Latin America Small Molecule Drug Discovery Market Analysis, By Process/Phase, 2019, 2023 and 2033
- Figure 92. Latin America Small Molecule Drug Discovery Market Attractiveness Analysis, By Process/Phase
- Figure 93. Latin America Small Molecule Drug Discovery Market (US$ Mn), by Target ID/Validation, 2019-2033
- Figure 94. Latin America Small Molecule Drug Discovery Market (US$ Mn), by Hit Generation and Selection, 2019-2033
- Figure 95. Latin America Small Molecule Drug Discovery Market (US$ Mn), by Lead Identification, 2019-2033
- Figure 96. Latin America Small Molecule Drug Discovery Market (US$ Mn), by Lead Optimization, 2019-2033
- Figure 97. Latin America Small Molecule Drug Discovery Market Analysis, By End Users, 2019, 2023 and 2033
- Figure 98. Latin America Small Molecule Drug Discovery Market Attractiveness Analysis, By End Users
- Figure 99. Latin America Small Molecule Drug Discovery Market (US$ Mn), by Pharmaceutical companies, 2019-2033
- Figure 100. Latin America Small Molecule Drug Discovery Market (US$ Mn), by Biotechnology companies, 2019-2033
- Figure 101. Latin America Small Molecule Drug Discovery Market (US$ Mn), by Contract research organizations (CROs), 2019-2033
- Figure 102. Latin America Small Molecule Drug Discovery Market (US$ Mn), by Others, 2019-2033
- Figure 103. Latin America Small Molecule Drug Discovery Market Analysis, By Country, 2019, 2023 and 2033
- Figure 104. Latin America Small Molecule Drug Discovery Market Attractiveness Analysis, By Country
- Figure 105. Middle East and Africa Small Molecule Drug Discovery Market Analysis, By Therapeutic Area, 2019, 2023 and 2033
- Figure 106. Middle East and Africa Small Molecule Drug Discovery Market Attractiveness Analysis, By Therapeutic Area
- Figure 107. Middle East and Africa Small Molecule Drug Discovery Market (US$ Mn), by Oncology, 2019-2033
- Figure 108. Middle East and Africa Small Molecule Drug Discovery Market (US$ Mn), by Central Nervous System, 2019-2033
- Figure 109. Middle East and Africa Small Molecule Drug Discovery Market (US$ Mn), by Cardiovascular, 2019-2033
- Figure 110. Middle East and Africa Small Molecule Drug Discovery Market (US$ Mn), by Respiratory, 2019-2033
- Figure 111. Middle East and Africa Small Molecule Drug Discovery Market (US$ Mn), by Metabolic Disorders, 2019-2033
- Figure 112. Middle East and Africa Small Molecule Drug Discovery Market (US$ Mn), by Gastrointestinal, 2019-2033
- Figure 113. Middle East and Africa Small Molecule Drug Discovery Market (US$ Mn), by Other Therapeutic Areas, 2019-2033
- Figure 114. Middle East and Africa Small Molecule Drug Discovery Market Analysis, By Process/Phase, 2019, 2023 and 2033
- Figure 115. Middle East and Africa Small Molecule Drug Discovery Market Attractiveness Analysis, By Process/Phase
- Figure 116. Middle East and Africa Small Molecule Drug Discovery Market (US$ Mn), by Target ID/Validation, 2019-2033
- Figure 117. Middle East and Africa Small Molecule Drug Discovery Market (US$ Mn), by Hit Generation and Selection, 2019-2033
- Figure 118. Middle East and Africa Small Molecule Drug Discovery Market (US$ Mn), by Lead Identification, 2019-2033
- Figure 119. Middle East and Africa Small Molecule Drug Discovery Market (US$ Mn), by Lead Optimization, 2019-2033
- Figure 120. Middle East and Africa Small Molecule Drug Discovery Market Analysis, By End Users, 2019, 2023 and 2033
- Figure 121. Middle East and Africa Small Molecule Drug Discovery Market Attractiveness Analysis, By End Users
- Figure 122. Middle East and Africa Small Molecule Drug Discovery Market (US$ Mn), by Pharmaceutical companies, 2019-2033
- Figure 123. Middle East and Africa Small Molecule Drug Discovery Market (US$ Mn), by Biotechnology companies, 2019-2033
- Figure 124. Middle East and Africa Small Molecule Drug Discovery Market (US$ Mn), by Contract research organizations (CROs), 2019-2033
- Figure 125. Middle East and Africa Small Molecule Drug Discovery Market (US$ Mn), by Others, 2019-2033
- Figure 126. Middle East and Africa Small Molecule Drug Discovery Market Analysis, By Country, 2019, 2023 and 2033
- Figure 127. Middle East and Africa Small Molecule Drug Discovery Market Attractiveness Analysis, By Country
- Pfizer Inc Company Profile
- GlaxoSmithKline PLC
- Merck & Co. Inc.
- Agilent Technologies Inc. Company Profile
- Eli Lilly and Company
- Hoffmann-La Roche Ltd
- Bayer AG Company Profile
- Abbott Laboratories Inc.
- Thermo Fisher Scientific Company Profile
- Shimadzu Corp
- Halia Therapeutics
- Sibylla Biotech
- Other Key Players
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 127107
Published Date Aug 2024
Rating
- ★★★★★
  
  ★★★★★
- (61)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)